Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting 2021-06-07 10:00
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication 2021-06-07 08:30
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries 2021-06-07 08:00
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021 2021-06-07 08:00
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting 2021-06-07 08:00
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 2021-06-07 08:00
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 2021-06-07 08:00
Singapore/ US based TurtleTree ready to commercialize Human Lactoferrin as first major product 2021-06-05 01:32
DiNovA's Israel Incubator officially opens its office in Caesarea 2021-06-04 14:00
Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting 2021-06-04 13:56
Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021 2021-06-04 08:00
Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy 2021-06-04 08:00
The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial 2021-06-04 02:00
RWDC Industries Appoints New Chief Financial Officer 2021-06-03 22:00
Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy for People with Squamous Non-Small Cell Lung Cancer 2021-06-03 17:09
Peking University Biologics entering into Strategic Cooperation Agreement with Norwich Investment Limited 2021-06-03 16:29
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology's Medical Journal "Blood" 2021-06-03 08:00
First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma 2021-06-03 06:00
Nanoform raises its mid-term business targets for 2025 2021-06-02 21:42
CPF launches plant-based "MEAT ZERO", eyeing to make it world's Top 3 alternative meat brand in 3-5 years 2021-06-02 17:40